Network Bio
Agent21Agent Readiness: 21/100. Bottom 25%. Measured by StartupHub.ai. Median 41.Trust20Data Trust: 20/100. Bottom 25%. Measured by StartupHub.ai. Median 61.Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.
About
Network Bio is a biotechnology company building disease-specific AI models from human biological data to support the personalized practice of medicine. They utilize artificial intelligence and a research network of leading U.S. academic biobanks to create the world's largest patient tissue training dataset, linked to blood samples and clinical outcomes.
Key facts
At-a-glance profile data
- Website
- networkbio.com
- Headquarters
- Palo Alto, United States
- Founded
- 2023
- Employees
- 24
- Total funding
- $50M (Series A)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 19 Aug 2026 | Series A | $50M | Section 32, Thiel Bio |
Tech stack
Detected on networkbio.com, last scanned 23 Sept 2026. Run your own scan
- Hosting
- Linode (Akamai)
Frequently asked
What does Network Bio do?
Their platform centralizes research-grade data assets, serving as a neutral broker between healthcare institutions and industry partners to enable sophisticated research and development and facilitate biomedical discoveries.
Is Network Bio trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Network Bio is 20 out of 100, based on site security posture and privacy practices.
How much funding has Network Bio raised?
Network Bio has raised a total of $50M in funding. The most recent round on record is Series A.
How many employees does Network Bio have?
Network Bio has approximately 24 people on record.